Biobanking Market - A Global and Regional Analysis

2.1 Equipment
      2.1.1 Storage Equipment
      2.1.2 Sample Analysis Equipment
      2.1.3 Sample Processing Equipment
      2.1.4 Sample Transport Equipment
2.2 Consumables
      2.2.1 Storage Consumables
      2.2.2 Analysis Consumables
      2.2.3 Processing Consumables
      2.2.4 Collection Consumables
2.3 Services
      2.3.1 Storage Services
      2.3.2 Processing Services
      2.3.3 Transport Services
      2.3.4 Supply Services
2.4 Software

3.1 Manual Storage
3.2 Automated Storage

4.1 Blood Products
4.2 Human Tissues
4.3 Cell Lines
4.4 Nucleic Acids
4.5 Biological Fluids
4.6 Human Waste Products

5.1 Universities
5.2 National/Regional Agencies
5.3 Non-Profit Organizations
5.4 Private Organizations

6.1 Physical/Real Biobanks
6.2 Tissue Biobanks
6.3 Population-Based Biobanks
6.4 Genetic (DNA/RNA)
6.5 Disease-Based Biobanks
6.6 Virtual Biobanks

7.1 Regenerative Medicine
7.2 Life Science Research
7.3 Clinical Research

8.1 Pharmaceutical & Biotechnology Companies and Cros
8.2 Academic And Research Institutes
8.3 Hospitals

9.1 North America
      9.1.1 Key Findings
      9.1.2 Market Dynamics
      9.1.3 Market Sizing and Forecast
               9.1.3.1 North America Biobanking Market, by Country
9.1.3.1.1 U.S.
9.1.3.1.2 Canada
9.2 Europe
      9.2.1 Key Findings
      9.2.2 Market Dynamics
      9.2.3 Market Sizing and Forecast
               9.2.3.1 Europe Biobanking Market, by Country
                           9.2.3.1.1 Germany
                           9.2.3.1.2 U.K.
                           9.2.3.1.3 France
                           9.2.3.1.4 Italy
                           9.2.3.1.5 Spain
                           9.2.3.1.6 Rest of the Europe
9.3 Asia Pacific
      9.3.1 Key Findings
      9.3.2 Market Dynamics
      9.3.3 Market Sizing and Forecast
               9.3.3.1 Asia Pacific Biobanking Market, by Country
                           9.3.3.1.1 China
                           9.3.3.1.2 Japan
                           9.3.3.1.3 India
                           9.3.3.1.4 Australia
                           9.3.3.1.5 Rest of Asia Pacific
9.4 Rest of the World
      9.4.1 Key Findings
      9.4.2 Market Dynamics
      9.4.3 Market Sizing and Forecast

10.1 Key Strategies and Development
        10.1.1 Mergers and Acquisitions
        10.1.2 Synergistic Activities
        10.1.3 Business Expansions and Funding
        10.1.4 Product Launches and Approvals
        10.1.5 Other Activities
10.2 Company Profiles
        10.2.1 Becton, Dickinson and Company
                   10.2.1.1 Overview
                   10.2.1.2 Top Products / Product Portfolio
                   10.2.1.3 Top Competitors
                   10.2.1.4 Target Customers/End-Users
                   10.2.1.5 Key Personnel
                   10.2.1.6 Analyst View
        10.2.2 QIAGEN N.V.
                   10.2.2.1 Overview
                   10.2.2.2 Top Products / Product Portfolio
                   10.2.2.3 Top Competitors
                   10.2.2.4 Target Customers/End-Users
                   10.2.2.5 Key Personnel
                   10.2.2.6 Analyst View
        10.2.3 Merck KGaA
                   10.2.3.1 Overview
                   10.2.3.2 Top Products / Product Portfolio
                   10.2.3.3 Top Competitors
                   10.2.3.4 Target Customers/End-Users
                   10.2.3.5 Key Personnel
                   10.2.3.6 Analyst View                   
        10.2.4 Thermo Fisher Scientific Inc.
                   10.2.4.1 Overview
                   10.2.4.2 Top Products / Product Portfolio
                   10.2.4.3 Top Competitors
                   10.2.4.4 Target Customers/End-Users
                   10.2.4.5 Key Personnel
                   10.2.4.6 Analyst View
        10.2.5 PHC Holdings Corporation
                   10.2.5.1 Overview
                   10.2.5.2 Top Products / Product Portfolio
                   10.2.5.3 Top Competitors
                   10.2.5.4 Target Customers/End-Users
                   10.2.5.5 Key Personnel
                   10.2.5.6 Analyst View
        10.2.6 Cryoport, Inc.
                   10.2.6.1 Overview
                   10.2.6.2 Top Products / Product Portfolio
                   10.2.6.3 Top Competitors
                   10.2.6.4 Target Customers/End-Users
                   10.2.6.5 Key Personnel
                   10.2.6.6 Analyst View
        10.2.7 Azenta, Inc.
                   10.2.7.1 Overview
                   10.2.7.2 Top Products / Product Portfolio
                   10.2.7.3 Top Competitors
                   10.2.7.4 Target Customers/End-Users
                   10.2.7.5 Key Personnel
                   10.2.7.6 Analyst View
        10.2.8 Avantor, Inc.
                   10.2.8.1 Overview
                   10.2.8.2 Top Products / Product Portfolio
                   10.2.8.3 Top Competitors
                   10.2.8.4 Target Customers/End-Users
                   10.2.8.5 Key Personnel
                   10.2.8.6 Analyst View
        10.2.9 Tecan Trading AG
                   10.2.9.1 Overview
                   10.2.9.2 Top Products / Product Portfolio
                   10.2.9.3 Top Competitors
                   10.2.9.4 Target Customers/End-Users
                   10.2.9.5 Key Personnel
                   10.2.9.6 Analyst View
        10.2.10 Greiner AG
                   10.2.10.1 Overview
                   10.2.10.2 Top Products / Product Portfolio
                   10.2.10.3 Top Competitors
                   10.2.10.4 Target Customers/End-Users
                   10.2.10.5 Key Personnel
                   10.2.10.6 Analyst View
        10.2.11 Bay Biosciences LLC
                   10.2.11.1 Overview
                   10.2.11.2 Top Products / Product Portfolio
                   10.2.11.3 Top Competitors
                   10.2.11.4 Target Customers/End-Users
                   10.2.11.5 Key Personnel
                   10.2.11.6 Analyst View
        10.2.12 Shanghai Zhangjiang Biobank
                   10.2.12.1 Overview
                   10.2.12.2 Top Products / Product Portfolio
                   10.2.12.3 Top Competitors
                   10.2.12.4 Target Customers/End-Users
                   10.2.12.5 Key Personnel
                   10.2.12.6 Analyst View
        10.2.13 US Biolab Corporation, Inc.
                   10.2.13.1 Overview
                   10.2.13.2 Top Products / Product Portfolio
                   10.2.13.3 Top Competitors
                   10.2.13.4 Target Customers/End-Users
                   10.2.13.5 Key Personnel
                   10.2.13.6 Analyst View
        10.2.14 Cureline
                   10.2.14.1 Overview
                   10.2.14.2 Top Products / Product Portfolio
                   10.2.14.3 Top Competitors
                   10.2.14.4 Target Customers/End-Users
                   10.2.14.5 Key Personnel
                   10.2.14.6 Analyst View
        10.2.15 Brooks Life Sciences
                   10.2.15.1 Overview
                   10.2.15.2 Top Products / Product Portfolio
                   10.2.15.3 Top Competitors
                   10.2.15.4 Target Customers/End-Users
                   10.2.15.5 Key Personnel
                   10.2.15.6 Analyst View

Table: Global Biobanking  Market Dynamics, Impact Analysis
Table: Global Biobanking  Market (by Region), $Billion, 2024-2035

Figure: Global Biobanking  Market (by Product and Service), $Billion, 2024 and 2035
Figure: Global Biobanking  Market (by Storage Type), $Billion, 2024 and 2035
Figure: Global Biobanking  Market (by Sample Type), $Billion, 2024 and 2035
Figure: Global Biobanking  Market (by Ownership), $Billion, 2024 and 2035
Figure: Global Biobanking  Market (by Biobank Type), $Billion, 2024 and 2035
Figure: Global Biobanking  Market (by Application), $Billion, 2024 and 2035
Figure: Global Biobanking  Market (by End User), $Billion, 2024 and 2035
Figure: Global Biobanking  Market (by Region), $Billion, 2024 and 2035
Figure: Global Biobanking  Market Key Trends, Analysis